^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IMM2520

    i
    Other names: IMM2520
    Associations
    News
    Trials
    Company:
    ImmuneOnco Biopharma
    Drug class:
    PD-L1 inhibitor, CD47 inhibitor
    Related drugs:
    Associations
    News
    Trials